Home

Get set to hand over to Enstilar®

A once-daily, 4-week, topical fixed dose combination treatment for plaque psoriasis of the body and scalp in adults1

Advance to Enstilar® today!

Efficacy

*Dovobet® ointment is not available in Ireland


LEO Pharma Product Licence Indications
Enstilar® is indicated for the topical treatment of psoriasis vulgaris in adults.1  Prescribing information can be found here
Dovobet® ointment* is indicated for the topical treatment of stable plaque psoriasis vulgaris amenable to topical therapy in adults.2 Prescribing information can be found here
Dovobet® gel is indicated for scalp psoriasis in adults and the topical treatment of mild to moderate “non-scalp” plaque psoriasis vulgaris in adults.3.  Prescribing information can be found here

  1. Enstilar® SPC, UK www.medicines.org.uk / IE www.medicines.ie. Last accessed: August 2020.
  2. Dovobet®  ointment SPC, www.medicines.org.uk. Last accessed: August 2020.
  3. Dovobet®  gel SPC, UK www.medicines.org.uk / IE www.medicines.ie. Last accessed: August 2020.

MAT-25249 V2 August 2020

Keep in touch with LEO Pharma

Latest product information, consultation tools, hot topics in dermatology and congress updates.  Be the first to know with LEO Pharma. Sign up

MAT-29941 November 2019

Holler Box